CGEM stock

Cullinan Oncology LLC (CGEM) financials · $830.3M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cullinan Oncology LLC (CGEM) $830.3M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$241.6M-$196.9M
Net Income-$219.9M-$167.4M
Cached annual balance sheet
LineFY2025FY2024
Total Assets$448.4M$621.8M
Current Assets$386.8M$414.7M
Cash & Equivalents$88.3M$83.0M
PP&E$421.0K$683.0K
Total Liabilities$39.6M$31.5M
Current Liabilities$37.7M$30.6M
Shareholders' Equity$408.7M$590.3M
Retained Earnings-$588.1M-$368.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$175.8M-$145.3M
CapEx$49.0KN/A
Investing Cash Flow$180.0M-$136.3M
Financing Cash Flow$1.09M$266.2M
Free Cash Flow-$175.8M-$145.3M
These statements as JSON? API free 100/day

FAQ

What is CGEM P/E and revenue?

Cullinan Oncology LLC (CGEM) $830.3M cap.

What is CGEM revenue?

CGEM income-statement cache has no revenue figure yet.

Is CGEM profitable?

Cullinan Oncology LLC last cached net income is -$219.9M (FY2025).

What are CGEM total assets?

Cullinan Oncology LLC last cached total assets are $448.4M (FY2025).

What is CGEM free cash flow?

Cullinan Oncology LLC last cached free cash flow is -$175.8M (FY2025).

Not investment advice. Cached statements, not a live tape.